P2Y12 Inhibitor Monotherapy and Percutaneous Coronary Intervention
Transitioning to P2Y12 inhibitor monotherapy sooner reduces complications and side effects in patients undergoing PCI. Read to know more.
Inhibitor Immunotherapy- An Overview
Inhibitor immunotherapy represents a type of immunotherapy for various types of cancers. The article below provides detailed information on the same.
